These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23726377)

  • 21. [Distal spinal-muscular atrophy 1 (DSMA1 or SMARD1)].
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Gressens P; Schuelke M; Hubner C; von Au K
    Arch Pediatr; 2008 Oct; 15(10):1568-72. PubMed ID: 18804971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights.
    Saladini M; Nizzardo M; Govoni A; Taiana M; Bresolin N; Comi GP; Corti S
    J Cell Mol Med; 2020 Jan; 24(2):1169-1178. PubMed ID: 31802621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.
    Porro F; Rinchetti P; Magri F; Riboldi G; Nizzardo M; Simone C; Zanetta C; Faravelli I; Corti S
    J Neurol Sci; 2014 Nov; 346(1-2):35-42. PubMed ID: 25248952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands.
    Pennuto M; Greensmith L; Pradat PF; Sorarù G;
    Neuromuscul Disord; 2015 Oct; 25(10):802-12. PubMed ID: 26206601
    [No Abstract]   [Full Text] [Related]  

  • 25. The natural course of infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Eckart M; Guenther UP; Idkowiak J; Varon R; Grolle B; Boffi P; Van Maldergem L; Hübner C; Schuelke M; von Au K
    Pediatrics; 2012 Jan; 129(1):e148-56. PubMed ID: 22157136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.
    Shababi M; Feng Z; Villalon E; Sibigtroth CM; Osman EY; Miller MR; Williams-Simon PA; Lombardi A; Sass TH; Atkinson AK; Garcia ML; Ko CP; Lorson CL
    Mol Ther; 2016 May; 24(5):855-66. PubMed ID: 26860981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal muscular atrophy with respiratory distress type 1 associated with novel compound heterozygous mutations in IGHMBP2: Differential diagnosis in a case with congenital diaphragm eventration.
    Yasui Y; Sato H; Niida Y; Kohno M
    Congenit Anom (Kyoto); 2019 Jan; 59(1):22-23. PubMed ID: 29575095
    [No Abstract]   [Full Text] [Related]  

  • 28. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th--13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June--1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France.
    Mercuri E; Mayhew A; Muntoni F; Messina S; Straub V; Van Ommen GJ; Voit T; Bertini E; Bushby K;
    Neuromuscul Disord; 2008 Nov; 18(11):894-903. PubMed ID: 18818076
    [No Abstract]   [Full Text] [Related]  

  • 29. An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1).
    Wu S; Chen T; Li Y; Chen L; Xu Q; Xiao F; Bai Z
    Eur J Med Genet; 2018 Oct; 61(10):602-606. PubMed ID: 29653221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th - 21st 2021.
    Detering NT; Zambon A; Hensel N; Kothary R; Swoboda K; Gillingwater TH; Baranello G; ;
    Neuromuscul Disord; 2022 Aug; 32(8):697-705. PubMed ID: 35794048
    [No Abstract]   [Full Text] [Related]  

  • 31. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands.
    Zerres K; Davies KE
    Neuromuscul Disord; 1999 Jun; 9(4):272-8. PubMed ID: 10399757
    [No Abstract]   [Full Text] [Related]  

  • 32. Spinal muscular atrophy with respiratory distress type 1 (SMARD1) Report of a Spanish case with extended clinicopathological follow-up.
    San Millan B; Fernandez JM; Navarro C; Reparaz A; Teijeira S
    Clin Neuropathol; 2016; 35(2):58-65. PubMed ID: 26709713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic Odyssey and Application of Targeted Exome Sequencing in the Investigation of Recurrent Infant Deaths in a Syrian Consanguineous Family: a Case of Spinal Muscular Atrophy with Respiratory Distress Type 1.
    Kim YA; Jin HY; Kim YM
    J Korean Med Sci; 2019 Mar; 34(9):e54. PubMed ID: 30863264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined Genome Sequencing and RNA Analysis Reveals and Characterizes a Deep Intronic Variant in IGHMBP2 in a Patient With Spinal Muscular Atrophy With Respiratory Distress Type 1.
    Bodle EE; Zhu W; Velez-Bartolomei F; Tesi-Rocha A; Liu P; Bernstein JA
    Pediatr Neurol; 2021 Jan; 114():16-20. PubMed ID: 33189025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diaphragmatic weakness with progressive sensory and motor polyneuropathy: case report of a neonatal IGHMBP2-related neuropathy.
    Gitiaux C; Bergounioux J; Magen M; Quijano-Roy S; Blanc T; Bonnefont JP; Desguerre I
    J Child Neurol; 2013 Jun; 28(6):787-90. PubMed ID: 22791546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal muscular atrophy with respiratory distress type 1: A multicenter retrospective study.
    Viguier A; Lauwers-Cances V; Cintas P; Manel V; Peudenier S; Desguerre I; Quijano-Roy S; Vanhulle C; Fradin M; Isapof A; Jokic M; Mathieu-Dramard M; Dieterich K; Petit F; Magdelaine C; Giuliano F; Gras D; Haye D; Nizon M; Magen M; Bieth E; Cances C
    Neuromuscul Disord; 2019 Feb; 29(2):114-126. PubMed ID: 30598237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 191st ENMC international workshop: recent advances in oculopharyngeal muscular dystrophy research: from bench to bedside 8-10 June 2012, Naarden, The Netherlands.
    Raz V; Butler-Browne G; van Engelen B; Brais B
    Neuromuscul Disord; 2013 Jun; 23(6):516-23. PubMed ID: 23578714
    [No Abstract]   [Full Text] [Related]  

  • 38. Neonatal spinal muscular atrophy presenting as respiratory distress: a clinical variant.
    Schapira D; Swash M
    Muscle Nerve; 1985 Oct; 8(8):661-3. PubMed ID: 4058474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
    Hamilton MJ; Longman C; O'Hara A; Kirkpatrick M; McWilliam R
    Neuromuscul Disord; 2015 Feb; 25(2):169-71. PubMed ID: 25454169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and New Treatment Avenues in Spinal Muscular Atrophy.
    Pechmann A; Kirschner J
    Neuropediatrics; 2017 Aug; 48(4):273-281. PubMed ID: 28571100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.